Amarin Corporation plc (AMRN)
NASDAQ
Market Cap
$209.78M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
283 of 968
Rank in Industry
172 of 556
Largest Insider Buys in Sector
AMRN Stock Price History Chart
AMRN Stock Performance
About Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Insider Activity of Amarin Corporation plc
Over the last 12 months, insiders at Amarin Corporation plc have bought $118,124 and sold $26,963 worth of Amarin Corporation plc stock.
On average, over the past 5 years, insiders at Amarin Corporation plc have bought $174,734 and sold $11.85M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Berg Aaron (President and CEO) — $102,400. Holt Patrick (President and CEO) — $15,724.
The last purchase of 160,000 shares for transaction amount of $102,400 was made by Berg Aaron (President and CEO) on 2024‑08‑02.
List of Insider Buy and Sell Transactions, Amarin Corporation plc
| 2024-08-02 | President and CEO | 160,000 0.0389% | $0.64 | $102,400 | -7.05% | |||
| 2024-01-22 | President and CEO | 14,426 0.0033% | $1.09 | $15,724 | -29.33% | |||
| 2023-12-12 | Sale | Chief Scientific Officer | 34,131 0.0084% | $0.79 | $26,963 | +7.80% | ||
| 2023-08-16 | President and CEO | 300,000 0.0723% | $1.04 | $312,315 | -17.88% | |||
| 2022-06-13 | 55,000 0.0137% | $1.69 | $92,730 | -21.76% | ||||
| 2021-12-15 | director | 2,000 0.0005% | $3.15 | $6,310 | -52.31% | |||
| 2021-12-14 | director | 10,000 0.0025% | $3.27 | $32,689 | -52.00% | |||
| 2021-08-12 | Sale | SVP and CFO | 120,000 0.0282% | $5.25 | $630,240 | -41.05% | ||
| 2021-06-04 | director | 10,000 0.0026% | $4.54 | $45,350 | -17.42% | |||
| 2021-06-03 | director | 5,000 0.0013% | $4.62 | $23,115 | -19.61% | |||
| 2021-02-01 | Sale | Chief Scientific Officer | 435,456 0.11% | $8.06 | $3.51M | -39.85% | ||
| 2021-01-27 | Sale | Chief Scientific Officer | 843,258 0.2332% | $8.01 | $6.76M | -33.52% | ||
| 2020-11-30 | director | 50,000 0.0125% | $4.86 | $243,035 | +1.61% | |||
| 2020-11-11 | Sale | President and CEO | 827,130 0.2094% | $4.07 | $3.36M | +22.63% | ||
| 2020-11-10 | Sale | President and CEO | 307,680 0.0792% | $4.13 | $1.27M | +22.63% | ||
| 2020-03-04 | Sale | President and CEO | 400,000 0.1106% | $15.99 | $6.4M | -58.77% | ||
| 2020-01-03 | Sale | director | 600,000 0.0965% | $12.17 | $7.3M | -67.88% | ||
| 2019-12-16 | Sale | CHIEF COMMERCIAL OFFICER | 86,506 0.02% | $19.03 | $1.65M | -70.15% | ||
| 2019-12-16 | Sale | director | 200,000 0.0424% | $17.42 | $3.48M | -70.15% | ||
| 2019-12-16 | Sale | SVP and CFO | 50,000 0.0142% | $23.36 | $1.17M | -70.15% |
Insider Historical Profitability
20.36%
| Berg Aaron | President and CEO | 805380 0.1958% | $0.51 | 1 | 4 | |
| Ketchum Steven B | Chief Scientific Officer | 566100 0.1376% | $0.51 | 0 | 21 | |
| Holt Patrick | President and CEO | 314426 0.0765% | $0.51 | 2 | 0 | |
| SOFINNOVA VENTURE PARTNERS VII L P | 10 percent owner | 8513388 2.0701% | $0.51 | 0 | 7 | |
| HEALY JAMES | director | 5513388 1.3406% | $0.51 | 0 | 4 | |
| THERO JOHN F | President and CEO | 2739000 0.666% | $0.51 | 6 | 9 | +54.85% |
| Abingworth LLP | 10 percent owner | 1599168 0.3888% | $0.51 | 0 | 11 | |
| Kalb Michael Wayne | SVP and CFO | 205010 0.0498% | $0.51 | 0 | 8 | |
| Zakrzewski Joseph S | director | 196547 0.0478% | $0.51 | 3 | 16 | <0.0001% |
| WOLD OLSEN PER | 149000 0.0362% | $0.51 | 1 | 0 | <0.0001% | |
| STACK DAVID M | director | 40000 0.0097% | $0.51 | 3 | 4 | <0.0001% |
| Kennedy Joseph T | General Counsel | 31260 0.0076% | $0.51 | 0 | 27 | |
| VAN HEEK G JAN | director | 14168 0.0034% | $0.51 | 0 | 3 | |
| Farrell Michael James | Controller | 6037 0.0015% | $0.51 | 1 | 0 | +140.48% |
| ORBIMED ADVISORS LLC | director | 5700 0.0014% | $0.51 | 0 | 21 | |
| GORDON CARL L | director | 5700 0.0014% | $0.51 | 0 | 21 | |
| SEDLACK STUART D | Senior Vice President | 0 0% | $0.51 | 0 | 1 | |
| Ekman Lars | director | 0 0% | $0.51 | 1 | 5 | <0.0001% |
| Ahlholm Frederick W | Vice President Finance | 0 0% | $0.51 | 0 | 2 | |
| Soni Paresh | SVP and Head of Development | 0 0% | $0.51 | 0 | 2 | |
| Peterson Kristine | director | 0 0% | $0.51 | 0 | 1 | |
| Huff Paul | Chief Commercial Officer | 0 0% | $0.51 | 0 | 6 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Sarissa Capital Management LP | $22.14M | 6.05 | 24.85M | 0% | +$0 | 3.87 | |
| Kynam Capital Management Lp | $10.71M | 2.93 | 12.02M | 0% | +$0 | 0.14 | |
| DG Capital | $5.74M | 1.57 | 6.44M | +19.23% | +$925,812.88 | 3.72 | |
| Eversept Partners LP | $5.53M | 1.51 | 6.21M | +1.92% | +$104,440.07 | 0.43 | |
| Morgan Stanley | $3.22M | 0.88 | 3.61M | -35.1% | -$1.74M | <0.0001 | |
| Two Sigma | $3.02M | 0.83 | 3.39M | +6.6% | +$187,142.83 | 0.01 | |
| Two Sigma Advisers LP | $2.51M | 0.68 | 2.81M | +3.1% | +$75,448.98 | <0.01 | |
| Tang Capital Management, LLC | $2.23M | 0.61 | 2.5M | -19% | -$522,493.40 | 0.01 | |
| Scp Investment Lp | $2.23M | 0.61 | 2.5M | 0% | +$0 | 1.4 | |
| Longitude Cayman Ltd | $2.1M | 0.57 | 2.35M | +14.88% | +$271,450.00 | 3.06 | |
| Millennium Management LLC | $1.38M | 0.38 | 1.54M | -39.15% | -$885,247.85 | <0.01 | |
| Gsa Capital Partners Llp | $1.32M | 0.36 | 1.48M | +74.41% | +$563,579.08 | 0.11 | |
| Ameriprise Financial | $1.04M | 0.29 | 1.17M | -4.98% | -$54,664.79 | <0.0001 | |
| Hayek Kallen Investment Management | $906,000.00 | 0.25 | 1.02M | 0% | +$0 | 0.35 | |
| 13D Management LLC | $811,970.00 | 0.22 | 911,507 | +0.11% | +$919.30 | 0.5 | |
| Resources Investment Advisors Inc | $750,949.00 | 0.21 | 843,005 | +1.86% | +$13,704.96 | 0.01 | |
| LCM Capital Management Inc | $719,908.00 | 0.2 | 808,159 | +9.19% | +$60,574.40 | 0.47 | |
| Raymond James Financial Services Advisors Inc | $588,789.00 | 0.16 | 660,966 | +5.53% | +$30,839.52 | <0.01 | |
| Quinn Opportunity Partners Llc | $532,298.00 | 0.15 | 597,550 | 0% | +$0 | 0.04 | |
| Citadel Advisors LLC | $528,048.00 | 0.14 | 592,779 | -56.62% | -$689,260.67 | <0.0001 | |
| Waterfront Wealth Inc | $462,409.00 | 0.13 | 525,644 | +35.92% | +$122,198.24 | 0.15 | |
| Bleakley Financial Group Llc | $417,650.00 | 0.11 | 468,848 | 0% | +$0 | 0.01 | |
| Simplicity Wealth Llc | $417,650.00 | 0.11 | 468,848 | New | +$417,650.00 | 0.01 | |
| UBS | $393,923.00 | 0.11 | 442,113 | -35.23% | -$214,244.69 | <0.0001 | |
| Cutter Co Brokerage Inc | $390,622.00 | 0.11 | 438,901 | -0.61% | -$2,403.00 | 0.07 | |
| Group One Trading | $373,091.00 | 0.1 | 418,827 | +28.66% | +$83,114.29 | 0.01 | |
| Goldman Sachs | $346,086.00 | 0.1 | 388,511 | -28.7% | -$139,290.99 | <0.0001 | |
| State Street | $338,840.00 | 0.09 | 380,377 | -2.21% | -$7,645.74 | <0.0001 | |
| Regis Management Co LLC | $312,000.00 | 0.09 | 350,000 | 0% | +$0 | 0.1 | |
| BlackRock | $222,442.00 | 0.06 | 249,710 | +25.45% | +$45,119.09 | <0.0001 | |
| Geode Capital Management | $199,139.00 | 0.05 | 223,551 | +4.28% | +$8,165.06 | <0.0001 | |
| Nj State Employees Deferred Compensation Plan | $194,194.00 | 0.05 | 218,000 | 0% | +$0 | 0.02 | |
| Johnson Financial Group | $178,160.00 | 0.05 | 200,000 | 0% | +$0 | 0.01 | |
| Macquarie Group | $169,000.00 | 0.05 | 190,000 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $163,047.00 | 0.05 | 183,096 | -2.82% | -$4,733.90 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $143,093.00 | 0.04 | 160,635 | +13.29% | +$16,783.49 | <0.0001 | |
| Evanson Asset Management | $118,840.00 | 0.03 | 133,408 | 0% | +$0 | 0.02 | |
| American Financial Advisors, LLC | $103,674.00 | 0.03 | 116,382 | 0% | +$0 | 0.02 | |
| Checchi Capital Advisers | $93,342.00 | 0.03 | 104,785 | 0% | +$0 | 0.01 | |
| Hightower Advisors | $90,000.00 | 0.03 | 102,691 | +4.04% | +$3,494.27 | <0.0001 | |
| JPMorgan Chase | $86,852.00 | 0.02 | 97,499 | +9.51% | +$7,545.07 | <0.0001 | |
| Northern Trust | $82,840.00 | 0.02 | 92,995 | New | +$82,840.00 | <0.0001 | |
| T. Rowe Price | $79,000.00 | 0.02 | 87,745 | 0% | +$0 | <0.0001 | |
| Janney Montgomery Scott LLC | $74,000.00 | 0.02 | 83,270 | +5.47% | +$3,837.30 | <0.0001 | |
| Integrated Wealth Concepts Llc | $69,999.00 | 0.02 | 78,580 | -12.38% | -$9,887.87 | <0.01 | |
| China Universal Asset Management Co., Ltd. | $66,078.00 | 0.02 | 74,178 | +66.32% | +$26,349.07 | 0.01 | |
| Mirae Asset Global Investments Co Ltd | $95,285.00 | 0.02 | 67,063 | -46.3% | -$82,148.02 | <0.0001 | |
| Westside Investment Management Inc | $58,111.00 | 0.02 | 65,235 | -45.4% | -$48,325.62 | 0.01 | |
| Creative Planning | $56,576.00 | 0.02 | 63,512 | +52.07% | +$19,372.95 | <0.0001 | |
| Royal Bank of Canada | $53,000.00 | 0.02 | 60,623 | 0% | +$0 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.